Straumann is pleased to introduce Emdogain 015, a versatile and cost-effective way to treat patients with periodontal disease. Emdogain 015 is the same effective product clinicians have relied on for ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. All countries have their keywords. In Germany, it is Schuld. In the singular it means guilt, in the plural, ...

If you want to know who really controls Straumann Holding AG (VTX:STMN), then you'll have to look at the makeup of its share registry. We can see that retail investors own the lion's share in the ...

Junfeng Yao, Founder, President, and CEO of Smartee, stated: "The strategic collaboration between Smartee and the Straumann Group represents not only a strong commercial alliance built on ...

Subepithelial connective tissue grafts (SCTGs) with a coronally advanced flap (CAF) are accepted as the gold standard for covering denuded root surfaces. In recent years, enamel matrix derivatives ...

Good morning or afternoon to all of you. Thank you for attending this conference call on the Straumann Group's half year results 2025. Please take note of the disclaimer in our media release and on ...

Aug 13 (Reuters) - Swiss dental implant maker Straumann (STMN.S), opens new tab on Wednesday reported first half earnings below market expectations, impacted by negative foreign exchange movements and ...

Straumann Group, a leading player in the dental implant industry, reported its second-quarter 2025 earnings, showcasing a robust financial performance with a revenue of CHF 667.5 million. The company ...

Straumann will invest CHF 60 to 80 million over the next five years at the Villeret site Production for products sold in China will progressively transfer to the newly licensed Shanghai campus to ...

Brazil: A recent case series published in the Journal of Medical Case Reports has spotlighted the potential of Emdogain, an enamel matrix derivative, as a promising scaffold in regenerative endodontic ...